DXCM vs RXO · P/E 63, rev $2.50B vs rev $5.74B
DexCom Inc (DXCM) versus RXO Inc. (RXO) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
RXO Inc. (RXO) is a trucking company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported RXO revenue for 2025-12-31 was $5.74B. Net income was -$100.0M. Revenue was up 26.2% from 2024-12-31 to 2025-12-31. RXO currently screens at market cap $4.09B.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. RXO currently screens at market cap $4.09B.
Not investment advice. Open the DXCM and RXO stock pages for the full models.
Not investment advice.